Clinical Studies

Developing new treatments is important for continually improving patient care. Please click on the following links to learn more about KalVista's clinical trials:

KOMPLETE logo

KVD824-201 (KOMPLETE Study) is a Phase 2 clinical trial to evaluate KVD824 for the prevention of hereditary angioedema (HAE) attacks.

NIH Clinical Trials Listing


KONFIDENT logo

KVD900-301 (KONFIDENT Study) is a Phase 3 clinical trial to evaluate sebetralstat for the on-demand treatment of hereditary angioedema (HAE) attacks. 

NIH Clinical Trials Listing